BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24807543)

  • 21. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress.
    Bursać S; Brdovčak MC; Pfannkuchen M; Orsolić I; Golomb L; Zhu Y; Katz C; Daftuar L; Grabušić K; Vukelić I; Filić V; Oren M; Prives C; Volarevic S
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20467-72. PubMed ID: 23169665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
    Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
    J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.
    Wu CE; Esfandiari A; Ho YH; Wang N; Mahdi AK; Aptullahoglu E; Lovat P; Lunec J
    Br J Cancer; 2018 Feb; 118(4):495-508. PubMed ID: 29235570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2-P53 pathway.
    Zhu Y; Ren C; Jiang D; Yang L; Chen Y; Li F; Wang B; Zhang Y
    Cancer Sci; 2021 May; 112(5):1811-1821. PubMed ID: 33675124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.
    Kayama K; Watanabe S; Takafuji T; Tsuji T; Hironaka K; Matsumoto M; Nakayama KI; Enari M; Kohno T; Shiraishi K; Kiyono T; Yoshida K; Sugimoto N; Fujita M
    EMBO Rep; 2017 Jan; 18(1):123-137. PubMed ID: 27856536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of tumor suppressor RPL5/RPL11 does not induce cell cycle arrest but impedes proliferation due to reduced ribosome content and translation capacity.
    Teng T; Mercer CA; Hexley P; Thomas G; Fumagalli S
    Mol Cell Biol; 2013 Dec; 33(23):4660-71. PubMed ID: 24061479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5.
    Dai MS; Lu H
    J Biol Chem; 2004 Oct; 279(43):44475-82. PubMed ID: 15308643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
    Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
    Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence.
    Fregoso OI; Das S; Akerman M; Krainer AR
    Mol Cell; 2013 Apr; 50(1):56-66. PubMed ID: 23478443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway.
    Franklin DA; Liu S; Jin A; Cui P; Guo Z; Arend KC; Moorman NJ; He S; Wang GG; Wan YY; Zhang Y
    J Biol Chem; 2023 Jan; 299(1):102739. PubMed ID: 36435197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop.
    Zhang X; Wang W; Wang H; Wang MH; Xu W; Zhang R
    Oncogene; 2013 May; 32(22):2782-91. PubMed ID: 22777350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pre-existing population of 5S rRNA effects p53 stabilization during ribosome biogenesis inhibition.
    Onofrillo C; Galbiati A; Montanaro L; Derenzini M
    Oncotarget; 2017 Jan; 8(3):4257-4267. PubMed ID: 28032591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells.
    Ding L; Zhang Z; Zhao C; Chen L; Chen Z; Zhang J; Liu Y; Nie Y; He Y; Liao K; Zhang X
    J Exp Clin Cancer Res; 2021 Aug; 40(1):245. PubMed ID: 34362424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new PICTure of nucleolar stress.
    Suzuki A; Kogo R; Kawahara K; Sasaki M; Nishio M; Maehama T; Sasaki T; Mimori K; Mori M
    Cancer Sci; 2012 Apr; 103(4):632-7. PubMed ID: 22320853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway.
    Wang B; Gao J; Zhao Z; Zhong X; Cui H; Hou H; Zhang Y; Zheng J; Di J; Liu Y
    Mol Med; 2022 Sep; 28(1):109. PubMed ID: 36071402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDMX regulation of p53 response to ribosomal stress.
    Gilkes DM; Chen L; Chen J
    EMBO J; 2006 Nov; 25(23):5614-25. PubMed ID: 17110929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability.
    Kim TH; Leslie P; Zhang Y
    Oncotarget; 2014 Feb; 5(4):860-71. PubMed ID: 24658219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
    Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y
    Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perturbation of ribosome biogenesis drives cells into senescence through 5S RNP-mediated p53 activation.
    Nishimura K; Kumazawa T; Kuroda T; Katagiri N; Tsuchiya M; Goto N; Furumai R; Murayama A; Yanagisawa J; Kimura K
    Cell Rep; 2015 Mar; 10(8):1310-23. PubMed ID: 25732822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 is positively regulated by miR-542-3p.
    Wang Y; Huang JW; Castella M; Huntsman DG; Taniguchi T
    Cancer Res; 2014 Jun; 74(12):3218-27. PubMed ID: 24762395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.